Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline.

@article{Cornelia2001AntifungalAA,
  title={Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline.},
  author={Lass-Fl{\"o}rl Cornelia and Manfred Paul Dierich and Dietmar Fuchs and E. Semenitz and Maximilian Ledochowski},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2001},
  volume={33 12},
  pages={E135-6}
}
Three patients with premenstrual dysphoric disorder (PMDD) and recurrent vulvovaginal candidiasis (VVC) underwent sertraline therapy (Tresleen, a selective serotonin-reuptake inhibitor; Pfizer) for PMDD. During sertraline intervention, patients had no recurrent episodes of acute VVC. Antifungal activity was observed for sertraline against various isolates of Candida species. 
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Stress Response Mechanisms in Fungi

Springer International Publishing • 2018

References

Publications referenced by this paper.

Similar Papers

Loading similar papers…